Companies in the genetics sector developing innovative solutions and technologies.
Explore 345 recently funded genetics companies with verified founder contact information and fundraising data.
Cognigenics transforms mental health in the genetic age through cognitive neuroengineering.
Blacksmith Medicines developing medicines targeting metal-dependent enzymes found in human physiology.
Synthego is a genome engineering company that enables access to CRISPR to accelerate life science research and development.
GenoGra is a biotechnology company that specializes in genomic analysis using software tools and bioinformatics.
We are decentralizing the clinical lab to deliver universal, lab-grade diagnostics, accelerating time-to-action by 100x.
Humane Genomics is a virus development platform that develops artificial viruses to cure diseases.
Ocusphere Therapeutics Inc. is a biotech startup focused on gene therapy using non-viral vectors, targeting inherited retinal diseases.
Liberate Bio develops non-viral delivery technologies for nucleic acid cargoes, aiming to address genetic disorders.
Ensomaa is a genomic medicine company that develops on one-time in vivo treatments for immuno-oncology and other therapeutic applications.
Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
Gameto is a biotechnology company developing therapeutics of the female reproductive system using cell engineering.
SpayVac for Wildlife is a biotechnology firm that produces vaccines for fertility control with a single injection for wildlife animals.
Reborna Biosciences is a biotechnology firm offering research and development of RNA-targeting small molecule drugs for genetic diseases.
Actio Biosciences is a research center that develops drugs for rare diseases.
Ace Vision Group develop laser-based therapeutic technologies to heal age-related eye dysfunction and restore the eye's natural performance.
XAI Platform for Cancer Genomics Interpretation SaaS
Digital biotech startup offers an ecosystem of AI-powered solutions for genetic analysis and clinical decision support for rare diseases
Foment Bio is a clinical-stage biotechnology company developing non-viral, off-the-shelf, gene based products.
Topaz Biosciences develops biological solutions leveraging microbial diversity for research and skin health.
Uncommon Therapeutics focuses on building drugs for rare diseases using cutting-edge technology.
I Peace is a technology company that provides research and development services for GMP products, drug discovery, and personal iPSC banking.
Arctic Therapeutics is a drug discovery and development company that focuses on identifying genetic causes of major diseases.
Geneoscopy develops a screening methodology to noninvasively diagnose colorectal cancer using biomarkers in stool samples.
Hervolution Therapeutics develops immunotherapies targeting tumors using Human Endogenous Retroviral proteins (HERVs).
The genetics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Genetics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The genetics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 345 genetics companies tracked in the VCBacked database.
Companies in the genetics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting genetics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked